Suchergebnisse - "Simpson, Iain"

PubPharm (159)

1

Optimization of a series of novel, potent and selective Macrocyclic SYK inhibitors

enthalten in: Bioorganic & medicinal chemistry letters | 2023

von Grimster, N. | Gingipalli, L. | Balazs, A. | +34

2

Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRASG12C with Demonstrable CNS Penetration

enthalten in: Journal of medicinal chemistry | 2023

von Kettle, J. | Bagal, S. | Barratt, D. | +42

3

Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners

enthalten in: Molecular cancer therapeutics | 2023

von Doshi, A. | Cantin, S. | Hernandez, M. | +25

4

Industry update covering March 2023

enthalten in: Therapeutic delivery | 2023

von Simpson, I.

5

Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome Inhibitors

enthalten in: ACS medicinal chemistry letters | 2022

von Harrison, D. | Bock, M. | Doedens, J. | +9

6

Therapeutic delivery: industry update covering January 2022

enthalten in: Therapeutic Delivery | 2022

von Simpson, I.

7

Relation of High-Sensitivity Troponin to 1 Year Mortality in 20,000 Consecutive Hospital Patients Undergoing a Blood Test for Any Reason

enthalten in: The American journal of cardiology | 2021

von Hinton, J. | Mariathas, M. | Gabara, L. | +15

8

Industry news update covering June 2021

enthalten in: Therapeutic delivery | 2021

von Simpson, I.

9

Industry update covering January 2021

enthalten in: Therapeutic delivery | 2021

von Simpson, I.

10

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

enthalten in: European heart journal | 2021

von Collet, J. | Thiele, H. | Barbato, E. | +122

CommentIn: Eur Heart J. 2021 May 21;42(20):2019. - PMID 33167025

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]